Saxenda (liraglutide) : Also approved for weight management, particularly in those with weight-related health conditions
and (3) "No, and I do not plan to take them." Figure 1 shows that 11.8 percent of adults reported using GLP-1 agonists in 2025 about the same percentage of users reported in 2023 by KFF
Evidence from both preclinical and clinical studies supports their antiinflammatory roles in the cardiovascular system, liver, kidneys, and joints
Indians develop diabetes, fatty liver, and heart disease at a lower BMI and often carry more fat around the belly with less muscle (the thin-fat phenotype)
Ipamorelin can promote muscle protein synthesis and inhibit muscle protein breakdown by regulating growth hormone levels, thereby increasing muscle mass
Accordingly, AOXs were explored as a method to delay this ageing process